Adoptive regulatory T-cell therapy preserves systemic immune homeostasis after cerebral ischemia
Hepatic macrophage niche: a bridge between HBV-mediated metabolic changes with intrahepatic inflammation
When beginning a GLP-1 treatment, it is important to begin on the lowest dose for that specific medication and only increase gradually to give the body time to adjust
MS-based proteomics Hypothalamic tissue was powdered and lysed (lysis buffer 50 mM Tris, 4% SDS buffer, pH 8.5) using BeatBox homogenizer (PreOmics)
Any use of GLP-1 agonists for binge eating disorder is off-label and should involve specialist oversight with continued psychological support
GLP-1 receptor agonists (semaglutide, tirzepatide, liraglutide) work by suppressing appetite, slowing digestion, and regulating blood sugar leading to significant, often rapid weight loss